Found 24 matching trials
Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS PHASE2 This study compares the safety and effectiveness of giving rivogenlecleucel...
Show More Location
TriStar Bone Marrow Transplant, LLC
Learn More & Join Trial
Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD) PHASE1 To find the highest and/or recommended dose of TROP2-CAR-NK cells combined ...
Show More Status
Active Not Recruiting
Location
MD Anderson Cancer Center
Learn More & Join Trial
Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT PHASE1 This is a Phase I, multicenter, open-label, non-randomized study of matched...
Show More Location
Multiple Locations
Learn More & Join Trial
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study PHASE1 This is a long-term follow up study evaluating the safety of BPX-501 T cell...
Show More Location
IRCCS Ospedale Pediatrico Bambino Gesù
Learn More & Join Trial
Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL PHASE1 The body has different ways of fighting infection and disease. No single wa...
Show More Status
Active Not Recruiting
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Learn More & Join Trial
Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma PHASE1 This Phase 1/2 study evaluates the safety, tolerability, and preliminary ef...
Show More Location
Peking University Shenzhen Hospital
Learn More & Join Trial
T-cells Expressing an Anti-SLAMF7 CAR for Treating Multiple Myeloma PHASE1 Background:
Multiple myeloma is a blood cancer that is usually incurable. ...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant PHASE1 This study will evaluate pediatric patients with malignant or non-malignant...
Show More Location
IRCCS Ospedale Pediatrico Bambino Gesù
Learn More & Join Trial
Safety & Activity of Controllable PRAME-TCR Therapy in Previously Treated AML/MDS or Metastatic Uveal Melanoma PHASE1 The purpose of this study is to evaluate the safety and activity of BPX-701...
Show More Location
Colorado Blood Cancer Institute
Learn More & Join Trial
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant PHASE1 This study will evaluate patients with blood cell cancers who are going to ...
Show More Status
Active Not Recruiting
Location
Emory University Winship Cancer Institute
Learn More & Join Trial